Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Ombitasvir/ABT-450/Ritonavir with Sofosbuvir with or without Ribavirin for chronic hepatitis C virus infection has completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ombitasvir/ABT-450/Ritonavir with Sofosbuvir (ombitasvir / ABT-450 / ritonavir / sofosbuvir)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2018-07-06